Janus Henderson Group plc 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:22 pm Purchase | 2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN | JANUS HENDERSON GROUP PLC JHG | 7,379,309 7.300% | 566,146 (+8.31%) | Filing |
| 2024-11-14 10:28 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | JANUS HENDERSON GROUP PLC JHG | 6,813,163 6.800% | 6,813,163 (New Position) | Filing |